English, Article edition: Economic Evaluation of Vaccination Programmes: A Consensus Statement Focusing on Viral Hepatitis Philippe Beutels; W. John Edmunds; Fernando Antonanzas; ...

User activity

Share to:
 
Bookmark: http://trove.nla.gov.au/version/93380
Physical Description
  • article
Language
  • English

Edition details

Title
  • Economic Evaluation of Vaccination Programmes: A Consensus Statement Focusing on Viral Hepatitis
Author
  • Philippe Beutels
  • W. John Edmunds
  • Fernando Antonanzas
  • G. Ardine de Wit
  • David Evans
  • Rachel Feilden
  • A. Mark Fendrick
  • Gary M. Ginsberg
  • Henry A. Glick
  • Eric Mast
  • Marc Pechevis
  • Eddy K.A. Van Doorslaer
  • Ben A. van Hout
Physical Description
  • article
Notes
  • The methods that have been used to estimate the clinical and economic impact of vaccination programmes are not always uniform, which makes it difficult to compare results between economic analyses. Furthermore, the relative efficiency of vaccination programmes can be sensitive to some of the more controversial aspects covered by general guidelines for the economic evaluation of healthcare programmes, such as discounting of health gains and the treatment of future unrelated costs. In view of this, we interpret some aspects of these guidelines with respect to vaccination and offer recommendations for future analyses. These recommendations include more transparency and validation, more careful choice of models (tailored to the infection and the target groups), more extensive sensitivity analyses, and for all economic evaluations (also nonvaccine related) to be in better accordance with general guidelines. We use these recommendations to interpret the evidence provided by economic evaluation applied to viral hepatitis vaccination. We conclude that universal hepatitis B vaccination (of neonates, infants or adolescents) seems to be the most optimal strategy worldwide, except in the few areas of very low endemicity, where the evidence to enable a choice between selective and universal vaccination remains inconclusive. While targeted hepatitis A vaccination seems economically unattractive, universal hepatitis A vaccination strategies have not yet been sufficiently investigated to draw general conclusions.
  • Hepatitis A, Hepatitis A vaccine, Hepatitis B, Hepatitis B vaccine, Immunisation programmes, Pharmacoeconomics, Practice guideline, Vaccines
  • RePEc:wkh:phecon:v:20:y:2002:i:1:p:1-7
Language
  • English
Contributed by
OAIster

Get this edition

  • Set up My libraries

    How do I set up "My libraries"?

    In order to set up a list of libraries that you have access to, you must first login or sign up. Then set up a personal list of libraries from your profile page by clicking on your user name at the top right of any screen.

  • All (1)
  • Unknown (1)
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.

User activity


e.g. test cricket, Perth (WA), "Parkes, Henry"

Separate different tags with a comma. To include a comma in your tag, surround the tag with double quotes.

Be the first to add a tag for this edition

Be the first to add this to a list

Comments and reviews

What are comments? Add a comment

No user comments or reviews for this version

Add a comment